Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This observational study is following people with Attention deficit hyperactivity disorder, Mental and Behavioural Disorders, or Hyperkinetic disorders to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In CanadaThis study is directly about ADHD.
This study is looking at whether 1 can help people with Attention deficit hyperactivity disorder, Mental and Behavioural Disorders, or Disturbance of activity and attention. Participants take part in 1 and complete follow-up assessments.
In AustraliaThis study is directly about ADHD.
This study is recruiting in France. It focuses on ADHD.
In AmiensThis study is directly about ADHD.
This study is recruiting in the United Kingdom. It focuses on ADHD.
In United KingdomThis study is directly about ADHD.
This study is recruiting in Germany. It focuses on ADHD.
In GermanyThis study is directly about ADHD.
This study is looking at a support or therapy approach for people with Attention-deficit/hyperactivity disorder, Mental and Behavioural Disorders, or Hyperkinetic disorders. Participants take part in the program or support approach and complete follow-up assessments.
In GermanyThis study is directly about ADHD.
This study is recruiting in the United States. It focuses on ADHD.
In BethesdaThis study is directly about ADHD.
This study is recruiting in Australia. It focuses on ADHD.
In AustraliaThis study is directly about ADHD.
This study is recruiting in Germany. It focuses on ADHD.
In GermanyThis study is directly about ADHD.
This study is looking at a support or therapy approach for people with Attention Deficit Hyperactivity Disorder or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.
In SpainThis study is directly about ADHD.
This study is looking at whether a digital support tool can help people with Attention-Deficit Hyperactivity Disorder or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.
In GermanyThis study is directly about ADHD.
This study is looking at evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD for people with Attention-Deficit/Hyperactivity Disorder. Participants receive 100mg SPN-812 or placebo and complete study visits and assessments.
Multiple locations, including SaralandThis study is directly about ADHD.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.